As of Jul 31
| +1.76 / +3.31%|
The 10 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 68.00, with a high estimate of 95.00 and a low estimate of 11.00. The median estimate represents a +23.79% increase from the last price of 54.93.
The current consensus among 12 polled investment analysts is to Hold stock in Isis Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.